Reimagining cardiovascular health

A new approach for cardiovascular
risk stratification

With highly unaddressed medical needs

About US

Imageens is an Al clinical decision software development company with proprietary technology that addresses highly unmet medical needs by making the most of cardiovascular imaging data.

Starting off in cardiovascular prevention, we use our cutting-edge technology across various clinical areas, with the mission to transform and save patients’ lives.

Learn more About Us
Science

Meet
ArtFun+

ArtFun+ is a MDR CE class IIa and clinically-validated technology for measuring new predictive imaging biomarkers of cardiovascular events.
Learn more About the Science
Science

MRI-based
Precision Biomarkers

ArtFun+ measures novel MRI biomarkers based on arterial stiffness evaluation that are recognized as a major risk factor for cardiovascular diseases and significant predictors of mortality.
Learn more About the Science
Science

Detecting Early
Vascular Aging

ArtFun+ biomarkers predict and detect earliest sign of cardiovascular diseases across large at-risk and asymptomatic patients populations.
Learn more About the Science
Science

Most Clinically
Validated

ArtFun+ is the most published technology for measuring arterial stiffness by MRI. It was validated in a range of clinical application that increased the understanding of CV diseases.
Learn more About the Science
Science

Meet
ArtFun+

ArtFun+ is a MDR CE class IIa and clinically-validated technology for measuring new predictive imaging biomarkers of cardiovascular events.
Science

MRI-based
Precision Biomarkers

ArtFun+ measures novel MRI biomarkers based on arterial stiffness evaluation that are recognized as a major risk factor for cardiovascular diseases and significant predictors of mortality.
Science

Detecting Early
Vascular Aging

ArtFun+ biomarkers predict and detect earliest sign of cardiovascular diseases across large at-risk and asymptomatic patients populations.
Science

Most Clinically
Validated

ArtFun+ is the most published technology for measuring arterial stiffness by MRI. It was validated in a range of clinical application that increased the understanding of CV diseases.
Learn more About the Science
Science

Meet
ArtFun+

ArtFun+ is a MDR CE class IIa and clinically-validated technology for measuring new predictive imaging biomarkers of cardiovascular events.
Science

MRI-based
Precision Biomarkers

ArtFun+ measures novel MRI biomarkers based on arterial stiffness evaluation that are recognized as a major risk factor for cardiovascular diseases and significant predictors of mortality.
Science

Detecting Early
Vascular Aging

ArtFun+ biomarkers predict and detect earliest sign of cardiovascular diseases across large at-risk and asymptomatic patients populations.
Science

Most Clinically
Validated

ArtFun+ is the most published technology for measuring arterial stiffness by MRI. It was validated in a range of clinical application that increased the understanding of CV diseases.
Product | primary prevention

Our first positioning led to a new mode for monitoring cardio-vascular check-ups.

product | beyond primary prevention

Beyond primary prevention, we are using our cardiovascular imaging biomarkers to tackle a wider range of clinical applications.

Vascular
Diseases
Cardiac
Diseases
Brain
Diseases
Further
Diseases
Product | co design AI solution

We are also sharing our knowledge & approach to
co-design more predictive clinical decision AI solutions.

Create
Structured Database

Extract, store and index DICOM Data at a large scale with quality verification

Annotate
Your Database

Automatically recognisze the images’ format, Orientation, Exam Type and imaged Organ

Design
AI Algorithm

Use your Data Catalog as source for trainning

Trusted by over 60 of the World’s Leading Clinical Centers across 13 countries for their research or clinical practice.

Rooted in Scientific Excellence

10+
Years of R&D
77+
Scientific Papers
2M+
Medical Images
See Clinical Evidence

Featured in